During menopausal transition, sleep disturbance is one of the most common and burdensome manifestations experienced by women¹. This session will cover the impact on quality of life and options available to improve night-time sleep and daytime functioning.

1 - Schaedel, Zoe et al., Maturitas, Volume 206, 108821.

Idorsia Pharmaceuticals Ltd Sponsored Symposium: for UK healthcare professionals only.

Idorsia licensed medication will be discussed.

UK-DA-01304 January 2026